SARS-CoV-2 associated Guillain-Barre syndrome after awaking on the ICU: consider differentials

References (4)

1. Koca A, Talan L, Şahin T, Çınar G, Evren E, Karahan ZC, Günalp M, Altıntaş ND, Şener Ö. An unusual course of SARS-CoV-2 infection: Challenging diagnosis of Guillain- Barré Syndrome. Tuberk Toraks 2021; 69(2): 242-6
2. Khanlou H, Valdes-Sueiras M, Farthing C. Peripheral Neuropathy Induced by Lopinavir-Saquinavir-Ritonavir Combination Therapy in an HIV-Infected Patient. J Int Assoc Physicians AIDS Care (Chic) 2007; 6(3): 155
3. Becerra-Cuñat JL, Coll-Cantí J, Gelpí-Mantius E, Ferrer- Avellí X, Lozano-Sánchez M, Millán-Torné M, Ojanguren I, Ariza A, Olivé A. Miopatía y neuropatía inducida por cloroquina: tetraparesia progresiva con arreflexia que simula una polirradiculoneuropatía. A propósito de dos casos (Chloroquine-induced myopathy and neuropathy: progressive tetraparesis with areflexia that simulates a polyradiculoneuropathy. Two case reports). Rev Neurol 2003; 36(6): 523-6
4. Finsterer J, Scorza FA, Scorza CA, Fiorini AC. Peripheral neuropathy in COVID-19 is due to immune-mechanisms, pre-existing risk factors, anti-viral drugs, or bedding in the Intensive Care Unit. Arq Neuropsiquiatr 2021; S0004- 282X2021005016201.